Literature DB >> 19619048

Is the minimum inhibitory concentration of vancomycin an infallible predictor of the clinical outcome of Staphylococcus aureus bacteremia treated with vancomycin?

Federico Pea, Pierluigi Viale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19619048     DOI: 10.1086/603589

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

Review 1.  Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.

Authors:  Rasmus V Rasmussen; Vance G Fowler; Robert Skov; Niels E Bruun
Journal:  Future Microbiol       Date:  2011-01       Impact factor: 3.165

2.  Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.

Authors:  Rocío Falcón; Eva Mateo; Rosa Oltra; Estela Giménez; Eliseo Albert; Ignacio Torres; David Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-06       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.